Search

everythinglearnresearchcommunity

for

Search:↓

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Vaccination helps reduce long COVID symptoms in women with PCOS.

Menopause-related skin changes may increase fungal infections and inflammation.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

CLEC10A and interleukin-42 can help identify PCOS patients' response to Metformin treatment.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

COVID-19 can cause significant hair loss.

COVID-19 might cause gray hair to regain color.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

COVID-19 infection may cause hair loss.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

COVID-19 can cause intense hair loss in women, usually resolving in 1 to 4 months.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Vitamin D and its receptor regulate skin functions like cell growth, immunity, hair cycle, and tumor prevention.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Some drugs may help treat both COVID-19 and radiation injury.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Many people in Thailand have lingering symptoms after recovering from COVID-19.